Research Paper Volume 13, Issue 23 pp 25453—25465
A risk model based on autophagy-related lncRNAs for predicting prognosis and efficacy of immunotherapy and chemotherapy in gastric cancer patients
Figure 8. Differences in the expressions of marker genes for immune checkpoint inhibitors between low- and high-risk patients. (A) CD274 (PD-L1); (B) CD28; (C) TGFBR1; (D) TNFSF4 (OX40L). *P < 0.05, **P < 0.01, ***P < 0.001.